Skip Navigation

Details for High Impact Journal

Superfund Research Program

Annals of Neurology (impact factor: 10.422)

2013

2011

  • Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim H, Leverenz JB, Montine TJ, Ginghina C, Kang U, Cain KC, Aasly JO, Goldstein DS, Zhang J, Wang Y. 2011. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69(3):570-580. doi:10.1002/ana.22311 PMID:21400565 PMCID:PMC3117674

2010

  • Ticozzi N, LeClerc AL, Keagle PJ, Glass JD, Wills AM, van Blitterswijk M, Bosco DA, Rodriguez-Leyva I, Gellera C, Ratti A, Taroni F, McKenna-Yasek D, Sapp PC, Silvani V, Furlong CE, Brown RH, Landers JE. 2010. Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol 68(1):102-107. doi:10.1002/ana.21993 PMID:20582942 PMCID:PMC2945725

1996

  • Kushleika JV, Checkoway H, Woods JS. 1996. Selegiline and lymphocyte superoxide dismutase activities in Parkinson's disease. Ann Neurol 39:278-281. PMID:8602757
  • Kushleika JV, Checkoway H, Woods JS, Moon J, Smith-Weller T, Franklin GM, Swanson PD. 1996. Selegiline (L-Deprenyl) mediates increased lymphocyte cytosolic and mitochondrial superoxide dismutase activities in Parkinson's Disease. Ann Neurol 39(3):378-381.
Back
to Top